JPS5874615A - 癌治療用組成物 - Google Patents

癌治療用組成物

Info

Publication number
JPS5874615A
JPS5874615A JP56174406A JP17440681A JPS5874615A JP S5874615 A JPS5874615 A JP S5874615A JP 56174406 A JP56174406 A JP 56174406A JP 17440681 A JP17440681 A JP 17440681A JP S5874615 A JPS5874615 A JP S5874615A
Authority
JP
Japan
Prior art keywords
tissue
cancer
cells
brain tissue
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56174406A
Other languages
English (en)
Japanese (ja)
Inventor
ダニエル・マルバン−ド・ラ・トレ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS5874615A publication Critical patent/JPS5874615A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP56174406A 1980-05-01 1981-10-30 癌治療用組成物 Pending JPS5874615A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14541980A 1980-05-01 1980-05-01

Publications (1)

Publication Number Publication Date
JPS5874615A true JPS5874615A (ja) 1983-05-06

Family

ID=22513026

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56174406A Pending JPS5874615A (ja) 1980-05-01 1981-10-30 癌治療用組成物

Country Status (8)

Country Link
JP (1) JPS5874615A (es)
CA (1) CA1175741A (es)
CH (1) CH655659B (es)
DE (1) DE3116733A1 (es)
ES (1) ES8300477A1 (es)
FR (1) FR2481602A1 (es)
GB (1) GB2075988B (es)
MX (1) MX6826E (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2717227A (en) * 1954-12-22 1955-09-06 Helen L Dawson Composition containing nerve tissue extract and process of producing such extract
DE1095464B (de) * 1956-05-22 1960-12-22 Univ Tulane Verfahren zur Herstellung eines Heilmittels zur Behandlung von Schizophrenie und anderen Geisteskrankheiten

Also Published As

Publication number Publication date
CH655659B (es) 1986-05-15
FR2481602A1 (fr) 1981-11-06
ES501835A0 (es) 1982-11-01
ES8300477A1 (es) 1982-11-01
GB2075988A (en) 1981-11-25
GB2075988B (en) 1983-09-01
DE3116733A1 (de) 1982-04-01
MX6826E (es) 1986-08-08
CA1175741A (en) 1984-10-09
FR2481602B1 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
Kokaia et al. Brain insults in rats induce increased expression of the BDNF gene through differential use of multiple promoters
JPH03503633A (ja) 遺伝物質を血液脳関門に送る方法
CN1107365A (zh) 新型生理活性物质
Schiff Central thalamic deep‐brain stimulation in the severely injured brain: rationale and proposed mechanisms of action
Hefti et al. Nerve growth factor and Alzheimer's disease
Sun et al. Reduction of hippocampal-kindled seizure activity in rats by stereotactic radiosurgery
AU2006343439B2 (en) The use of nicotine, analogues thereof, precursors thereof or derivatives thereof in the treatment of various pathological processes capable of improvement with a-MSH administered in prophylactic or therapeutic form
Christ et al. The application of gene therapy to the treatment of erectile dysfunction
Martins et al. Experimental delayed radiation necrosis of the brain: Part 1: Effect of early dexamethasone treatment
RU2099080C1 (ru) Способ предотвращения развития рака
Visted et al. Progress and challenges for cell encapsulation in brain tumour therapy
JPS5874615A (ja) 癌治療用組成物
CN115006423B (zh) 四面体框架核酸在制备预防和/或治疗脑外伤后遗症的药物中的用途
Connor Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
US20110165131A1 (en) Methods for treating diseases and increasing longevity
Son et al. Inhibition of γ-irradiation induced adhesion molecules and NO production by alginate in human endothelial cells
Callaway Improving neurologic outcomes after out-of-hospital cardiac arrest
Holmes et al. Consequences of cortical dysplasia during development in rats
CN112641796B (zh) 一种缺血性脑卒中的神经保护药物
US4559228A (en) Composition and method for the treatment of cancer
PL188157B1 (pl) Zastosowanie pozakomórkowych proteinaz
CN114288316B (zh) 四面体框架核酸在制备治疗胰腺炎的药物中的用途
US4728511A (en) Composition and method for the treatment of cancer
AU3441793A (en) Enzyme castration of animals and tumor treatment
JPS62135431A (ja) 液状骨形成剤からなる注射液